| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.001 | 1 |